The nasal vaccine -- BBV154 -- received approval of the Drugs Controller General of India in November for restricted use in an emergency situation for those above 18 as a heterologous booster dose.from Moneycontrol Business News https://ift.tt/91UEuQZ
Comments
Post a Comment